Filing Flows › Comparisons › MASS vs BNGO
908 Devices vs Bionano Genomics: MASS and BNGO compared
908 Devices is the larger company: $16.1M of revenue in its latest quarter (Q2 2026) against $8.2M for Bionano Genomics (Q2 2026). 908 Devices is growing faster (+23% against +21% a year earlier). 908 Devices is more profitable, with an operating margin of -79.7% against -88.3%.
Where the money goes: MASS and BNGO
908 Devices (MASS) · Q2 2026
908 Devices, Q2 2026: revenue $16.1M (+23% year over year), operating margin -79.7%, net loss $11.9M, operating cash flow $3.2M. The chart follows the revenue to costs, profit and cash.
Bionano Genomics (BNGO) · Q2 2026
Bionano Genomics, Q2 2026: revenue $8.2M (+21% year over year), operating margin -88.3%, net loss $7.4M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.
| 908 Devices (MASS) | Bionano Genomics (BNGO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $16.1M | $8.2M |
| Revenue growth, Y/Y | +23% | +21% |
| Operating margin | -79.7% | -88.3% |
| Net earnings | −$11.9M | −$7.4M |
| Net margin | -74.0% | -90.8% |
| Operating cash flow | $3.2M | −$4.7M |
| Free cash flow | $3.0M | — |
Where the revenue comes from
908 Devices
- Device sales revenue: $11.0M (69%)
- Recurring revenue: $4.9M (31%)
- Contract revenue: $104K (1%)
Bionano Genomics
- Product: $7.7M (94%)
- Product and Service Other: $478K (6%)
Questions
Which is bigger, 908 Devices or Bionano Genomics?
908 Devices is the larger company: $16.1M of revenue in its latest quarter (Q2 2026) against $8.2M for Bionano Genomics (Q2 2026).
Is 908 Devices or Bionano Genomics growing faster?
908 Devices is growing faster (+23% against +21% a year earlier).
Which is more profitable, 908 Devices or Bionano Genomics?
908 Devices is more profitable, with an operating margin of -79.7% against -88.3%.
More: 908 Devices earnings · how 908 Devices makes money · Bionano Genomics earnings · how Bionano Genomics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 10, 2026). Fiscal quarters can end on different dates. Not investment advice.